Is Bristol-Myers Squibb’s ImClone Takeover Bid A Preemptive Grab?
BMS takeover bid may be aimed at thwarting a spin-off, controlling potential Erbitux competition.
BMS takeover bid may be aimed at thwarting a spin-off, controlling potential Erbitux competition.